-
Document de presse | 2024.01.05
The Institut Pasteur and Sensorion announce that their partnership to accelerate gene therapy programs targeting hearing disorders has been extended for five years
The framework extension agreement underlines the successful collaboration between Sensorion and the Institut Pasteur, involving the Hearing Institute, a research center of the Institut Pasteur, focused on the development of gene therapy programs Two gene therapy development programs are currently being conducted under this agreement, including SENS-501 (OTOF-GT) and GJB2-GT. Sensorion submitted a...
-
News | 2016.11.16
The Institut Pasteur of Iran held the 2016 MATI Regional Meeting of the Institut Pasteur international Network
100 participants were gathered from 7th to 9th November 2016 at the Institut Pasteur of Iran for the MATI Regional Meeting (Morocco, Algeria, Tunisia and Iran) of the Institut Pasteur International Network.The meting was opened by Pr. Hassan Hashemi, Minister of Health of the Islamic Republic of Iran, Pr. Mostafa Ghanei, Director of the Institut Pasteur of Iran, Mr. François Sénémaud,...
-
News | 2017.05.05
Summer school dedicated to the creation of life sciences companies
The Institut Pasteur, in partnership with the Medicen Paris Region competitiveness pole, is organizing the second edition of the summer university dedicated to the creation of a life sciences company on 6 and 7 July.This event aims to give the participants the essential keys to the launch of a life sciences company (biotech, medtech, e-health, etc.). The summer school will cover the initial...
-
News | 2017.06.16
MosKeyTool: a free and interactive tool to identify mosquitoes of the Euro-Mediterranean region
Vector-borne diseases account for more than 17% of infectious diseases, and cause more than one million deaths each year worldwide. Mosquitoes are among the main vectors of diseases, especially arboviruses (dengue, chikungunya, etc. ). The precise identification of mosquito species is an essential step for the laboratories involved in the surveillance and control of these diseases with high...
-
Document de presse | 2017.11.28
Right/left: the heart of the matter
1% of all newborns – approximately 8,000 babies a year in France – are affected by a heart defect. 15% of these defects can be linked to a known genetic cause, but many remain unexplained. Defects affecting the alignment of cardiac chambers represent approximately 20% of heart defects in infants. A team of scientists from the Institut Pasteur and the UMR-1163 joint research unit at the Imagine...
-
News | 2020.07.03
ARIAweb: a server for automated NMR structure calculation
The ARIA software suite developed at Institut Pasteur automates the analysis of NMR data to calculate three-dimensional structures of macromolecules. To improve the user experience for ARIA and provide a larger and easier access, tructural bioinformatics Unit has created the ARIAweb server, providing an online service for such computationally intensive calculations and offering a dedicated...
-
News | 2021.05.06
Creation of the startup SPIKIMM to develop monoclonal antibodies as an innovative treatment for Covid-19
The Institut Pasteur has recently signed an exclusive worldwide license agreement with the new biotech start-up SpikImm SAS, created by Truffle Capital, for the development of anti-SARS-CoV-2 (Covid-19) monoclonal antibodies for therapeutic and diagnostic use.Monoclonal antibody therapy is one of the most innovative ways currently available to treat Covid-19 patients and prevent severe forms of...
-
Portrait | 2018.07.02
3D research according to Albane Imbert, an engineer at the Institut Pasteur
Albane's digital fabrication laboratory, or Fab Lab for those in the know, can be found in the Institut Pasteur's newest building. This is the place where tools for innovative technology research projects are developed. Back in 2016, when Albane was creating smart objects for industry, the Institut Pasteur asked her if she would be interested in developing a prototyping platform for new...
-
Fiche maladie | 2015.10.06
Leishmaniasis
Leishmaniasis is a parasitic disease that causes severely debilitating cutaneous or visceral lesions, which can be fatal if left untreated. The plural form "leishmaniases" is sometimes used, as the disease is actually a group of diseases caused by different parasites of the genus Leishmania, transmitted by the bites of sandflies. These parasitic diseases are considered emerging neglected diseases...
-
Document de presse | 2021.10.11
SARS-CoV-2 Alpha, Beta and Delta variants display enhanced viral fusion properties compared to ancestral strains
In a new study published in EMBO Journal on October 2, 2021, scientists from the Institut Pasteur, the CNRS, Université de Paris, the Vaccine Research Institute and Sorbonne University examined the fusion mechanisms of different SARS-CoV-2 variants: Alpha (initially identified in the United Kingdom), Beta (initially identified in South Africa) and Delta (initially identified in India). The Delta...